We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Safety of an Accelerated Ferric Gluconate Inpatient Infusion Regimen.
- Authors
Gray, Erica; Parrott, Tate; McCluggage, Lauren
- Abstract
Background: Inpatient use of intravenous iron has been increasing. Ferric gluconate is traditionally given once daily. Twice-daily dosing provides faster iron repletion, but there are limited data to support the safety of twice-daily dosing. Objective: The aim of this study was to investigate the safety of twice-daily dosing for ferric gluconate compared with daily dosing. Methods: This was an institutional review board-approved retrospective observational study of hospitalized adult patients who received intravenous ferric gluconate 250 mg daily or twice daily between January 1 and April 3, 2022. The primary composite safety outcome included hypotension, infusion reaction, rapid response alert, or escalation in level of care. Secondary outcomes included total amount of iron received, hospital length of stay, and changes in laboratory values. Results: A total of 126 patients were included in this study, with 63 patients in each group. The primary outcome occurred in 29 patients (46%) in the twice-daily group compared with 36 patients (57.1%) in the daily group (relative risk = 0.81; 95% CI, 0.57-1.13; P = 0.212). Changes in iron, hemoglobin, and transferrin saturation were similar between the 2 groups. Median length of stay was statistically shorter in the twice-daily group (7.79 days) compared with the daily group (12.9 days; p = 0.006). Conclusions: In this retrospective single-center study of hospitalized adult patients, those who received intravenous ferric gluconate twice daily did not experience an increased rate of a composite safety outcome of hypotension, infusion reactions, or escalation in level of care compared with those with daily dosing.
- Subjects
IRON; IRON in the body; PATIENT safety; TRANSFERRIN; SCIENTIFIC observation; HEMOGLOBINS; HEART failure; RETROSPECTIVE studies; DESCRIPTIVE statistics; IRON compounds; INTRAVENOUS therapy; DRUG efficacy; MEDICAL records; ACQUISITION of data; CONFIDENCE intervals; LENGTH of stay in hospitals; HYPOTENSION; EVALUATION
- Publication
Journal of Pharmacy Technology, 2025, Vol 41, Issue 1, p8
- ISSN
8755-1225
- Publication type
Academic Journal
- DOI
10.1177/87551225241288144